These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9665655)
1. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Euchenhofer C; Maihófner C; Brune K; Tegeder I; Geisslinger G Neurosci Lett; 1998 May; 248(1):25-8. PubMed ID: 9665655 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor. Yamamoto T; Nozaki-Taguchi N Brain Res; 1996 Nov; 739(1-2):104-10. PubMed ID: 8955930 [TBL] [Abstract][Full Text] [Related]
3. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. Tegeder I; Niederberger E; Vetter G; Bräutigam L; Geisslinger G J Neurochem; 2001 Nov; 79(4):777-86. PubMed ID: 11723170 [TBL] [Abstract][Full Text] [Related]
4. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist-induced contractions of the pig isolated ureter. Mastrangelo D; Wisard M; Rohner S; Leisinger H; Iselin CE Urol Res; 2000 Dec; 28(6):376-82. PubMed ID: 11221916 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894 [TBL] [Abstract][Full Text] [Related]
6. Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats. Abe M; Oka T; Hori T; Takahashi S Brain Res; 2001 Oct; 916(1-2):41-9. PubMed ID: 11597589 [TBL] [Abstract][Full Text] [Related]
7. The role of cyclooxygenase-1 and -2 in the rat formalin test. Yamamoto T; Nozaki-Taguchi N Anesth Analg; 2002 Apr; 94(4):962-7, table of contents. PubMed ID: 11916805 [TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505 [TBL] [Abstract][Full Text] [Related]
9. The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Ochi T; Motoyama Y; Goto T Eur J Pharmacol; 2000 Mar; 391(1-2):49-54. PubMed ID: 10720634 [TBL] [Abstract][Full Text] [Related]
10. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat. Yamada M; Kawai M; Kawai Y; Mashima Y Curr Eye Res; 1999 Oct; 19(4):300-4. PubMed ID: 10520225 [TBL] [Abstract][Full Text] [Related]
11. Role of spinal cyclooxygenase (COX)-2 on thermal hyperalgesia evoked by carageenan injection in the rat. Yamamoto T; Nozaki-Taguchi N Neuroreport; 1997 Jul; 8(9-10):2179-82. PubMed ID: 9243607 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Giuliano F; Warner TD Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826 [TBL] [Abstract][Full Text] [Related]
13. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach. Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076 [TBL] [Abstract][Full Text] [Related]
14. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism. Klein T; Neuhaus K; Reutter F; Nüsing RM Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387 [TBL] [Abstract][Full Text] [Related]
15. Effect of constitutive- and inducible-cyclooxygenase in the carbachol-induced pituitary-adrenocortical response during social stress. Bugajski J; Gadek-Michalska A; Bugajski AJ J Physiol Pharmacol; 2002 Sep; 53(3):453-62. PubMed ID: 12369741 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP-kinase-dependent process. Dunlop ME; Muggli EE Kidney Int; 2002 May; 61(5):1729-38. PubMed ID: 11967022 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of COX in ocular tissues: an in vitro model to identify selective COX-2 inhibitors. García-Cabanes C; Palmero M; Bellot JL; Castillo M; Orts A J Ocul Pharmacol Ther; 2001 Feb; 17(1):67-74. PubMed ID: 11322639 [TBL] [Abstract][Full Text] [Related]
18. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Crew TE; Elder DJ; Paraskeva C Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736 [TBL] [Abstract][Full Text] [Related]
19. Effects of COX inhibition and LPS on formalin induced pain in the infant rat. Hunter D; Chai C; Barr GA Dev Neurobiol; 2015 Oct; 75(10):1068-79. PubMed ID: 25205468 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]